{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:30:35Z","timestamp":1777581035941,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Deep brain stimulation has been used since the 1980s for neurological disorders and the USA and Europe have now approved it for Parkinson\u2019s disease, essential tremor, dystonia, and epilepsy. Previous reviews have assessed the effects of deep brain stimulation on different neurological disorders. These reviews all had methodological limitations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a protocol for a systematic review based on searches of major medical databases (e.g. MEDLINE, EMBASE, CENTRAL) and clinical trial registries. Two review authors will independently extract data and conduct risk of bias assessment. We will include published and unpublished randomised clinical trial comparing deep brain stimulation versus no intervention, usual care, sham stimulation, medical treatment, or resective surgery for Parkinson\u2019s disease, essential tremor, dystonia, or epilepsy. The effects of deep brain stimulation will be analysed separately for each of the different diagnoses. Primary outcomes will be all-cause mortality, disease-specific symptoms, and serious adverse events. Secondary outcomes will be quality of life, depressive symptoms, executive functioning, level of functioning, and non-serious adverse events. Data will be analysed using fixed-effect and random-effects meta-analyses and Trial Sequential Analysis. Risk of bias will be assessed with the Cochrane Risk of Bias tool\u2014version 2, an eight-step procedure to assess if the thresholds for clinical significance are crossed, and the certainty of the evidence will be assessed by Grading of Recommendations, Assessment, Development and Evaluations (GRADE).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Deep brain stimulation is increasingly being used for different neurological diseases, and the effects are unclear based on previous evidence. There is a need for a comprehensive systematic review of the current evidence. This review will provide the necessary background for weighing the benefits against the harms when assessing deep brain stimulation as intervention for individual neurological disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO 306,556.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-022-02095-z","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T10:02:45Z","timestamp":1665655365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deep brain stimulation for neurological disorders: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-1958","authenticated-orcid":false,"given":"Johanne Juul","family":"Petersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Juul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Kamp","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus Christian","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"issue":"5","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18(5):459\u201380.","journal-title":"The Lancet Neurology"},{"issue":"8","key":"2095_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/jnnp-2018-320039","volume":"90","author":"ME Freitas","year":"2019","unstructured":"Freitas ME, Ruiz-Lopez M, Dalmau J, Erro R, Privitera M, Andrade D, et al. Seizures and movement disorders: phenomenology, diagnostic challenges and therapeutic approaches. J Neurol Neurosurg Psychiatry. 2019;90(8):920\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5694\/j.1326-5377.2010.tb03453.x","volume":"192","author":"MW Hayes","year":"2010","unstructured":"Hayes MW, Fung VS, Kimber TE, O\u2019Sullivan JD. Current concepts in the management of Parkinson\u2019s disease. Med J Aust. 2010;192(3):144\u20139.","journal-title":"Med J Aust"},{"issue":"10291","key":"2095_CR4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"5","key":"2095_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","volume":"11","author":"A Fasano","year":"2012","unstructured":"Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson\u2019s disease with deep brain stimulation. Lancet Neurology. 2012;11(5):429\u201342.","journal-title":"Lancet Neurology"},{"issue":"19","key":"2095_CR6","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJMcp1707928","volume":"378","author":"D Haubenberger","year":"2018","unstructured":"Haubenberger D, Hallett M. Essential tremor. N Engl J Med. 2018;378(19):1802\u201310.","journal-title":"N Engl J Med"},{"issue":"4","key":"2095_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14737175.2020.1737017","volume":"20","author":"JK Wong","year":"2020","unstructured":"Wong JK, Hess CW, Almeida L, Middlebrooks EH, Christou EA, Patrick EE, et al. Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes. Expert Rev Neurother. 2020;20(4):319\u201331.","journal-title":"Expert Rev Neurother"},{"issue":"12","key":"2095_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S1474-4422(11)70232-0","volume":"10","author":"J Phukan","year":"2011","unstructured":"Phukan J, Albanese A, Gasser T, Warner T. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurology. 2011;10(12):1074\u201385.","journal-title":"Lancet Neurology"},{"issue":"7","key":"2095_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863\u201373.","journal-title":"Mov Disord"},{"key":"2095_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40734-016-0047-6","volume":"3","author":"P Termsarasab","year":"2016","unstructured":"Termsarasab P, Thammongkolchai T, Frucht SJ. Medical treatment of dystonia. J Clin Mov Disord. 2016;3:19.","journal-title":"J Clin Mov Disord"},{"key":"2095_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fneur.2018.00176","volume":"9","author":"M Simonato","year":"2018","unstructured":"Simonato M. Epilepsy an update on disease mechanisms: the potential role of MicroRNAs. Front Neurol. 2018;9:176.","journal-title":"Front Neurol"},{"key":"2095_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","volume":"12","author":"L Forsgren","year":"2005","unstructured":"Forsgren L, Beghi E, \u00d5un A, Sillanp\u00e4\u00e4 M. The epidemiology of epilepsy in Europe \u2013 a systematic review. Eur J Neurol. 2005;12:245\u201353.","journal-title":"Eur J Neurol"},{"key":"2095_CR13","doi-asserted-by":"publisher","first-page":"680938","DOI":"10.3389\/fnins.2021.680938","volume":"15","author":"YC Wu","year":"2021","unstructured":"Wu YC, Liao YS, Yeh WH, Liang SF, Shaw FZ. Directions of deep brain stimulation for epilepsy and Parkinson\u2019s disease. Front Neurosci. 2021;15:680938.","journal-title":"Front Neurosci"},{"issue":"5","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2176\/nmc.ra.2015-0344","volume":"56","author":"R Hanaya","year":"2016","unstructured":"Hanaya R, Arita K. The new antiepileptic drugs: their neuropharmacology and clinical indications. Neurol Med Chir (Tokyo). 2016;56(5):205\u201320.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41582-018-0128-2","volume":"15","author":"AM Lozano","year":"2019","unstructured":"Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, et al. Deep brain stimulation: current challenges and future directions. Nat Rev Neurol. 2019;15(3):148\u201360.","journal-title":"Nat Rev Neurol"},{"key":"2095_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2741\/4586","volume":"23","author":"DJ Aum","year":"2018","unstructured":"Aum DJ, Tierney TS. Deep brain stimulation: foundations and future trends. Front Biosci. 2018;23:162\u201382.","journal-title":"Front Biosci"},{"issue":"2","key":"2095_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nurt.2008.12.003","volume":"6","author":"P Boon","year":"2009","unstructured":"Boon P, Raedt R, de Herdt V, Wyckhuys T, Vonck K. Electrical stimulation for the treatment of epilepsy. Neurotherapeutics. 2009;6(2):218\u201327.","journal-title":"Neurotherapeutics."},{"key":"2095_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2018.08.017","volume":"58","author":"JK Wong","year":"2019","unstructured":"Wong JK, Cauraugh JH, Ho KWD, Broderick M, Ramirez-Zamora A, Almeida L, et al. STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2019;58:56\u201362.","journal-title":"Parkinsonism Relat Disord."},{"issue":"10","key":"2095_CR19","first-page":"e3474","volume":"10","author":"S Bratsos","year":"2018","unstructured":"Bratsos S, Karponis D, Saleh SN. Efficacy and safety of deep brain stimulation in the treatment of Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Cureus. 2018;10(10):e3474.","journal-title":"Cureus"},{"issue":"4","key":"2095_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3171\/2016.11.JNS16715","volume":"128","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Taslimi S, Badhiwala JH, Witiw CD, Nassiri F, Odekerken VJJ, et al. Deep brain stimulation for Parkinson\u2019s disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2018;128(4):1199\u2013213.","journal-title":"J Neurosurg"},{"key":"2095_CR21","doi-asserted-by":"publisher","first-page":"25285","DOI":"10.1038\/srep25285","volume":"6","author":"CL Xie","year":"2016","unstructured":"Xie CL, Shao B, Chen J, Zhou Y, Lin SY, Wang WW. Effects of neurostimulation for advanced Parkinson\u2019s disease patients on motor symptoms: a multiple-treatments meta-analysas of randomized controlled trials. Sci Rep. 2016;6:25285.","journal-title":"Sci Rep"},{"issue":"1","key":"2095_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1017\/S1092852917000062","volume":"23","author":"A Elgebaly","year":"2018","unstructured":"Elgebaly A, Elfil M, Attia A, Magdy M, Negida A. Neuropsychological performance changes following subthalamic versus pallidal deep brain stimulation in Parkinson\u2019s disease: a systematic review and metaanalysis. CNS Spectr. 2018;23(1):10\u201323.","journal-title":"CNS Spectr"},{"issue":"443\u201352","key":"2095_CR23","volume":"123","author":"Y Altinel","year":"2019","unstructured":"Altinel Y, Alkhalfan F, Qiao N, Velimirovic M. Outcomes in lesion surgery versus deep brain stimulation in patients with tremor: a systematic review and meta-analysis. World Neurosurg. 2019;123(443\u201352): e8.","journal-title":"World Neurosurg"},{"key":"2095_CR24","doi-asserted-by":"publisher","first-page":"2486065","DOI":"10.1155\/2020\/2486065","volume":"2020","author":"G Lu","year":"2020","unstructured":"Lu G, Luo L, Liu M, Zheng Z, Zhang B, Chen X, et al. Outcomes and adverse effects of deep brain stimulation on the ventral intermediate nucleus in patients with essential tremor. Neural Plast. 2020;2020:2486065.","journal-title":"Neural Plast"},{"key":"2095_CR25","first-page":"CD012405","volume":"1","author":"FB Rodrigues","year":"2019","unstructured":"Rodrigues FB, Duarte GS, Prescott D, Ferreira J, Costa J. Deep brain stimulation for dystonia. Cochrane Database Syst Rev. 2019;1:CD012405.","journal-title":"Cochrane Database Syst Rev."},{"key":"2095_CR26","first-page":"CD008497","volume":"7","author":"M Sprengers","year":"2017","unstructured":"Sprengers M, Vonck K, Carrette E, Marson AG, Boon P. Deep brain and cortical stimulation for epilepsy. Cochrane Database Syst Rev. 2017;7:CD008497.","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"2095_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/mds.26827","volume":"32","author":"AI Troster","year":"2017","unstructured":"Troster AI, Jankovic J, Tagliati M, Peichel D, Okun MS. Neuropsychological outcomes from constant current deep brain stimulation for Parkinson\u2019s disease. Mov Disord. 2017;32(3):433\u201340.","journal-title":"Mov Disord"},{"issue":"4","key":"2095_CR28","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1212\/WNL.0000000000009946","volume":"95","author":"ML Hacker","year":"2020","unstructured":"Hacker ML, Turchan M, Heusinkveld LE, Currie AD, Millan SH, Molinari AL, et al. Deep brain stimulation in early-stage Parkinson\u2019s disease: five-year outcomes. Neurology. 2020;95(4):e393\u2013401.","journal-title":"Neurology"},{"key":"2095_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/01.WNL.0000103235.12621.C3","volume":"62","author":"RAJ Esselink","year":"2004","unstructured":"Esselink RAJ, de Bie RMA, de Haan RJ, Lenders MWPM, Nijssen PCG, Staal MJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD. Neurology. 2004;62:201\u20137.","journal-title":"Neurology"},{"issue":"7","key":"2095_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJM200002173420703","volume":"342","author":"PR Schuurman","year":"2000","unstructured":"Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000;342(7):461\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"2095_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2009.07.003","volume":"462","author":"VC Anderson","year":"2009","unstructured":"Anderson VC, Burchiel KJ, Hart MJ, Berk C, Lou JS. A randomized comparison of thalamic stimulation and lesion on self-paced finger movement in essential tremor. Neurosci Lett. 2009;462(2):166\u201370.","journal-title":"Neurosci Lett"},{"issue":"6","key":"2095_CR32","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.brs.2018.08.006","volume":"11","author":"D Gruber","year":"2018","unstructured":"Gruber D, Sudmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, et al. Neurostimulation in tardive dystonia\/dyskinesia: A delayed start, sham stimulation-controlled randomized trial. Brain Stimul. 2018;11(6):1368\u201377.","journal-title":"Brain Stimul"},{"issue":"10","key":"2095_CR33","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/epi.13860","volume":"58","author":"A Cukiert","year":"2017","unstructured":"Cukiert A, Cukiert CM, Burattini JA, Mariani PP, Bezerra DF. Seizure outcome after hippocampal deep brain stimulation in patients with refractory temporal lobe epilepsy: a prospective, controlled, randomized, double-blind study. Epilepsia. 2017;58(10):1728\u201333.","journal-title":"Epilepsia"},{"issue":"3","key":"2095_CR34","first-page":"294","volume":"139","author":"H Herrman","year":"2019","unstructured":"Herrman H, Egge A, Konglund AE, Ramm-Pettersen J, Dietrichs E, Tauboll E. Anterior thalamic deep brain stimulation in refractory epilepsy: a randomized, double-blinded study. Acta Neurol Scand. 2019;139(3):294\u2013304.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2095_CR35","first-page":"1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. BioMed Central. 2015;4(1):1.","journal-title":"BioMed Central"},{"key":"2095_CR36","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.","journal-title":"BMJ"},{"key":"2095_CR37","unstructured":"ICH harmonised guideline: Integrated addemdum to ICH E6(R1): Guideline for Good Clinical Practice (ICH-GCP). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2015. Available from: https:\/\/ichgcp.net\/da."},{"key":"2095_CR38","unstructured":"StataCorp. Stata Statistical Software: Release 16 2019. College Station, TX: StataCorp LLC http:\/\/www.stata.com."},{"key":"2095_CR39","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C. Copenhagen Trial Unit. TSA - trial sequential analysis. Available from: http:\/\/www.ctu.dk\/tsa\/."},{"key":"2095_CR40","unstructured":"Thorlund K, Engstr\u00f8m JW, J\u00f8rn., Brok J, Imberger G, Gluud C. User Manual for Trial Sequential Analysis (TSA) Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical Intervention Research. Available from: http:\/\/www.ctu.dk\/tsa\/files\/tsa_manual.pdf."},{"key":"2095_CR41","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021) Cochrane: Cochrane; 2021 [Available from: www.training.cochrane.org\/handbook."},{"issue":"10","key":"2095_CR42","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00134-018-5293-7","volume":"44","author":"A Lundh","year":"2018","unstructured":"Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Med. 2018;44(10):1603\u201312.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2095_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"2095_CR44","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7414","key":"2095_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta analyses. BMJ. 2003;327(7414):557.","journal-title":"BMJ"},{"issue":"20","key":"2095_CR46","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443\u201357.","journal-title":"Stat Med"},{"issue":"7109","key":"2095_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, George DS, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"2095_CR48","first-page":"1088","volume":"50","author":"C Begg","year":"1994","unstructured":"Begg C, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Int Biom Soc. 1994;50:1088\u2013101.","journal-title":"Int Biom Soc"},{"key":"2095_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","volume":"31","author":"DR Elbourne","year":"2002","unstructured":"Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002;31:140\u20139.","journal-title":"Int J Epidemiol"},{"key":"2095_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2288-10-90","volume":"10","author":"F Keus","year":"2010","unstructured":"Keus F, Wetterslev J, Gluud C, van Laarhoven CJ. Evidence at a glance: error matrix approach for overviewing available evidence. BMC Med Res Methodol. 2010;10:90.","journal-title":"BMC Med Res Methodol"},{"key":"2095_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2288-14-120","volume":"14","author":"JC Jakobsen","year":"2014","unstructured":"Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BioMed Central. 2014;14:120.","journal-title":"BioMed Central"},{"issue":"3","key":"2095_CR52","first-page":"177","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Elsevier Science Publishing. 1986;7(3):177\u201388.","journal-title":"Elsevier Science Publishing"},{"issue":"3","key":"2095_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/sim.4780060325","volume":"6","author":"D DeMets","year":"1987","unstructured":"DeMets D. Methods for combining randomized clinical trials: strengths and limitations. Stat Med. 1987;6(3):341\u20138.","journal-title":"Stat Med"},{"issue":"1","key":"2095_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2095_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64\u201375.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"2095_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2095_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","volume":"38","author":"J Brok","year":"2009","unstructured":"Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive\u2013Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38(1):287\u201398.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2095_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","volume":"38","author":"K Thorlund","year":"2009","unstructured":"Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38(1):276\u201386.","journal-title":"Int J Epidemiol"},{"key":"2095_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:86.","journal-title":"BMC Med Res Methodol"},{"key":"2095_CR60","first-page":"57","volume":"2","author":"K Horlund","year":"2010","unstructured":"Horlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology. 2010;2:57\u201366.","journal-title":"Clinical Epidemiology."},{"issue":"8","key":"2095_CR61","doi-asserted-by":"publisher","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","volume":"6","author":"G Imberger","year":"2016","unstructured":"Imberger G, Thorlund K, Gluud C, Wetterslev J. False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review. BMJ Open. 2016;6(8):e011890.","journal-title":"BMJ Open"},{"key":"2095_CR62","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"issue":"4","key":"2095_CR63","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132.","journal-title":"J Clin Epidemiol"},{"key":"2095_CR64","first-page":"677","volume":"169","author":"HJ Sch\u00fcnemann","year":"2003","unstructured":"Sch\u00fcnemann HJ, Best D, Vist G, Oxman AD. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. Can Med Assoc J. 2003;169:677\u201380.","journal-title":"Can Med Assoc J"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-02095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-022-02095-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-02095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T11:09:18Z","timestamp":1665659358000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-022-02095-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1186\/s13643-022-02095-z","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}